Q3 FY19-20 Financials and R&D Update

21 Financials CF Audited FY 16-17 Audited FY 17-18 Audited FY 18-19 Particulars Standalone Consolidated Standalone Consolidated Standalone Consolidated INR Crores Unaudited YTD Dec-19 Standalone Consolidated Net Sales 1,403 1,521 1,749 1,847 2,050 2,157 1,559 1,679 EBIDTA 186 169 181 168 169 181 189 202 EBIDTA % 13% 11% 10% 9% 8% 8% 12% 12% PBT 115 91 85 PAT 108 85 5050 64 69 72 118 126 85 64 58 61 85 93 EPS 56 99 45 44 34 30 32 59 63 Book Value 297 295 332 323 363 355 398 398 EPS is calculated based on trailing 12 months ✓ BOPP film margins, which has been running subdued in India domestic industry from last two years due to demand-supply mismatch, has witnessed improvement from Q4, FY18-19. ✓ Management focus shall continue to be on expanding specialty, R&D efforts, margin expansion projects and improving internal efficiencies.

View entire presentation